ZEVRA THERAPEUTICS INC. (ZVRA) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2021-02-12
2:23 pm
Sale
2021-02-0813GZevra Therapeutics, Inc.
ZVRA
Auctus Fund LLC450,000
2.380%
-550,000decrease
(-55.00%)
Filing
History
2021-02-11
8:14 pm
Purchase
2020-12-3113GZevra Therapeutics, Inc.
ZVRA
Mickle Travis C227,545
4.900%
227,545increase
(New Position)
Filing
History
2021-02-05
2:04 pm
Purchase
2021-01-2613GZevra Therapeutics, Inc.
ZVRA
Auctus Fund LLC1,000,000
8.580%
1,000,000increase
(New Position)
Filing
History
2021-01-14
09:00 am
Purchase
2021-01-0813GZevra Therapeutics, Inc.
ZVRA
Empery Asset Management, LP1,230,000
9.990%
1,230,000increase
(New Position)
Filing
History
Goto Prev, 0, 1